Results 261 to 270 of about 18,220 (284)

Chronic idiopathic eosinopenia and chronic spontaneous urticaria

The Journal of Allergy and Clinical Immunology: In Practice, 2023
Eli Magen, Eugene Merzon, Ilan Green, Israel Magen, Akim Geishin, Avivit Golan-Cohen, Shlomo Vinker, Ariel Israel   +7 more
openaire   +2 more sources

[Inducible urticaria and chronic spontaneous urticaria].

Annales de dermatologie et de venereologie, 2015
In the recently published 2013 revision of the guidelines of urticaria, chronic urticaria (CU) gathers chronic spontaneous urticaria (CSU) and inducible urticaria (IU), and excludes pseudourticarial rashes with more than 24h-lasting rash or more than 72h-lasting angiœdema.
openaire   +1 more source

Acupuncture for Chronic Spontaneous Urticaria

Annals of Internal Medicine, 2023
openaire   +2 more sources

Management of chronic spontaneous urticaria: practical parameters.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015
Chronic urticaria (CU) is a skin disorder characterized by transient, pruritic wheals persisting for longer than 6 weeks. According to the European Academy of Allergy and Clinical Immunology (EAACI) guidelines, CU can be categorized into two main types: chronic spontaneous urticaria (CSU), in which the wheals appear spontaneously, and inducible ...
A.V. Marzano, P. Pigatto, A. Cristaudo, F. Ayala, O. Rossi, G. Senna, M. Triggiani, R. Asero   +7 more
openaire   +3 more sources

Urticaria

Nature Reviews Disease Primers, 2022
P V Kolkhir, Kanokvalai Kulthanan, Jonathan Peter   +2 more
exaly  

Chronic spontaneous urticaria, treatment with antihistamines

Česká a slovenská farmacie
Chronic spontaneous urticaria is characterized by reccurent wheals lasting more than 6 weeks, it can persist for months or years. The disease can lead to a significant worsening in the quality of life. According to recent guidelines second-generation non-sedative antihistamines are the first-line treatment.
openaire   +2 more sources

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria

Journal of Allergy and Clinical Immunology, 2022
Marcus Maurer, Koremasa Hayama, Vipul Jain   +2 more
exaly  

The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes

Journal of Allergy and Clinical Immunology, 2021
Sarbjit Saini, John Schroeder, Donald MacGlashan Jr   +2 more
exaly  

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

New England Journal of Medicine, 2013
Marcus Maurer, Sarbjit Saini, Clive E Grattan   +2 more
exaly  

Omalizumab chronic spontaneous urticaria

Annals of Allergy, Asthma & Immunology, 2018
Eustachio Nettis, Luca Cegolon, Elisabetta Di Leo, Fabio Lodi Rizzini, Aikaterini Detoraki, Giorgio Walter Canonica   +5 more
openaire   +1 more source